12:35 Mon 20 Jul 2020
Redx Pharma plc - Result of General Meeting
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE EU MARKET ABUSE REGULATION (596/2014). UPON THE PUBLICATION OF THE ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
("Redx" or "the Company")
Result of General Meeting
The table below sets out the details of the votes put to shareholders:
Resolution number | Resolution name | Number of votes for & discretionary | % of votes for & discretionary | Number of votes against | % of votes against | % votes withheld | Total votes cast (including withheld) |
1 | Allot shares | 175,305,377 | 99.99% | 11,514 | 0.01% | 0.00% | 175,321,878 |
2 | Pre-emption rights | 175,305,377 | 99.99% | 11,514 | 0.01% | 0.00% | 175,321,878 |
3 | Increase borrowing powers | 175,306,863 | 99.99% | 10,028 | 0.01% | 0.00% | 175,321,878 |
Following the passing of the resolutions the Company intends to drawdown the Loan in a single tranche as soon as practicable.
Furthermore, as a consequence of the passing of the resolutions, together with the subscription agreement with
For further information, please contact:
| T: +44 1625 469 920 |
|
|
|
|
|
|
| T: +44 20 3368 3550 |
|
|
|
|
| T: +44 20 3705 9330 |
Claes Spång/ |
|
|
|
FTI Consulting | T: +44 20 3727 1000 |
|
|
About
Redx is a
If you would like to sign up to regular alerts from
This information is provided by RNS, the news service of the
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HEREDeep dive
